Stimulation of neovascularization by the anti-angiogenic factor PEDF

被引:60
作者
Apte, RS
Barreiro, RA
Duh, E
Volpert, O
Ferguson, TA
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA
[3] Northwestern Univ, Sch Med, Dept Urol, Chicago, IL USA
关键词
D O I
10.1167/iovs.04-0172
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Examine the effect of (pigment epithelium-derived growth factor; PEDF) on laser-induced choroidal neovascularization (CNV). METHODS. Adult C57Bl/6 mice were anesthetized and four laser spots were placed in each quadrant of the fundus with a krypton red laser (614 nm, 50 mum, 0.05 second, 200 mW). Animals were treated with various doses of PEDF administered with miniosmotic pumps implanted subcutaneously. Seven days after laser treatment, mice were perfused with 3% FITC high-molecular-weight dextran, the eyes enucleated, and neovascularization analyzed by confocal microscopy. Data were recorded as the volume of the neovascular complex. The effect of PEDF on endothelial cell migration, vascular tube formation in synthetic basement membrane, and VEGF production was also determined. RESULTS. Mice receiving a lower dose of PEDF (90 mug/mL) had significantly decreased areas of CNV. A high dose of PEDF ( 360 mug/mL) significantly increased CNV, whereas an intermediate dose (180 mug/mL) of PEDF had no effect. PEDF inhibited endothelial cell migration and vascular tube formation at lower doses (0.5-5 mug/mL). High doses of PEDF (25-50 mug/mL) stimulated endothelial cell migration, enhanced vascular tube formation in vitro, and stimulated VEGF production from endothelial cells. Neutralizing anti-VEGF antibody completely reversed the stimulatory effects of high doses of PEDF on CNV in vivo. CONCLUSIONS. PEDF demonstrates opposing effects on CNV and endothelial cell function. Whereas low doses are inhibitory, high doses can augment the development of the neovasculature. These results suggest that the effects of PEDF on neovascularization are more complex than originally believed and that caution should be exercised when PEDF therapies are considered.
引用
收藏
页码:4491 / 4497
页数:7
相关论文
共 32 条
  • [1] Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons - Evidence for a PEDF receptor
    Alberdi, E
    Aymerich, MS
    Becerra, SP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) : 31605 - 31612
  • [2] Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: Analysis of the binding site
    Alberdi, E
    Hyde, CC
    Becerra, SP
    [J]. BIOCHEMISTRY, 1998, 37 (30) : 10643 - 10652
  • [3] Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.0.CO
  • [4] 2-F
  • [5] Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287
  • [6] The role of Fas-FasL in the development and treatment of ischemic retinopathy
    Barreiro, R
    Schadlu, R
    Herndon, J
    Kaplan, HJ
    Ferguson, TA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (03) : 1282 - 1286
  • [7] Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646
  • [8] PEDF: Raising both hopes and questions in controlling angiogenesis
    Chader, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2122 - 2124
  • [9] Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
    Dawson, DW
    Volpert, OV
    Gillis, P
    Crawford, SE
    Xu, HJ
    Benedict, W
    Bouck, NP
    [J]. SCIENCE, 1999, 285 (5425) : 245 - 248
  • [10] The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
    Devy, L
    Blacher, S
    Grignet-Debrus, C
    Bajou, K
    Masson, R
    Gerard, RD
    Gils, A
    Carmeliet, G
    Carmeliet, P
    Declerck, PJ
    Noël, A
    Foidart, JM
    [J]. FASEB JOURNAL, 2002, 16 (02) : 147 - 154